Dosidal · Switzerland

Infanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer Injektionssuspension

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:619 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 619
atc: J07CA06
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1998-09-29
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J07CA06
authorisation_number: 619
form: PULSIN
holder: GlaxoSmithKline AG
holder_partner_nr: 1000930
it_number: 08.08.
name: Infanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer Injektionssuspension
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
5MaJrUHxRpMoqNTJKGNAJv3IFGke02q4I7RCLupoaUYimSQObQE8JUOoU3tpKJxdUTPvPkJQJQHzyewPXvbGjQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:619 · Related records in other markets · Dosidal